Published by Josh White on 2nd June 2021
(Sharecast News) - Clinical stage biotechnology company Destiny Pharma announced positive progress with its lead clinical programme, 'NTCD-M3', on Wednesday.
URL: http://www.digitallook.com/dl/news/story/31889131/...